Blokhin National Medical Research Center of Oncology, Moscow, Russia.
Institute for Cellular and Intracellular Symbiosis of the Ural Branch of the Russian Academy of Sciences, Orenburg, Russia.
Dokl Biochem Biophys. 2022 Dec;507(1):312-317. doi: 10.1134/S160767292205009X. Epub 2023 Feb 14.
The role of the immune system in tumor progression has been the subject of research for more than 100 years since Paul Ehrlich hypothesized that the presence of the immune system limits the occurrence of cancer. One of the mechanisms hindering the initiation and progression of the tumor is the cytotoxic activity of macrophages; however, in some cases, it is not sufficient to control tumorigenesis. This may be due to both the development of resistance of tumor cells to the antitumor activity of macrophages and the development of a tolerant phenotype of macrophages that do not have sufficient antitumor activity. In this work, the lung cancer cells resistant to the cytotoxic action of macrophages were obtained and characterized for the first time, and the genes associated with the observed changes were identified. Understanding the mechanisms of resistance of tumor cells to the cytotoxic activity of macrophages and the peculiarities of its manifestation in a tumor environment is critically important for improving the effectiveness of the existing methods of cancer treatment and developing novel methods for tumor immunotherapy.
免疫系统在肿瘤进展中的作用自 Paul Ehrlich 假设免疫系统的存在限制了癌症的发生以来,已经成为 100 多年来的研究课题。阻碍肿瘤发生和发展的机制之一是巨噬细胞的细胞毒性活性;然而,在某些情况下,这不足以控制肿瘤发生。这可能是由于肿瘤细胞对巨噬细胞的抗肿瘤活性产生了耐药性,以及巨噬细胞发展为具有足够抗肿瘤活性的耐受表型。在这项工作中,首次获得了对巨噬细胞细胞毒性作用具有抗性的肺癌细胞,并对其进行了表征,同时确定了与观察到的变化相关的基因。了解肿瘤细胞对巨噬细胞细胞毒性作用的耐药机制及其在肿瘤环境中的表现特点,对于提高现有癌症治疗方法的有效性和开发新的肿瘤免疫治疗方法至关重要。